Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance
Open Access
- 28 October 2010
- Vol. 341 (oct28 3), c5623
- https://doi.org/10.1136/bmj.c5623
Abstract
No funding was received for writing this summary.The degree of disability and negative impact on quality of life caused by psoriasis and psoriatic arthritis are comparable to those of ischaemic heart disease, diabetes, depression, and cancer.1 Severe psoriasis and psoriatic arthritis are associated with an increased risk of conditions such as cardiovascular disease, diabetes, and depression.2 3 4 5 Psoriatic arthritis is underdiagnosed; about a fifth of patients with psoriasis also have psoriatic arthritis.6 The management of patients with both conditions may be particularly challenging and require close collaboration among several specialties. This article summarises the most recent recommendations from the Scottish Intercollegiate Guidelines Network (SIGN) on the diagnosis and management of psoriasis and psoriatic arthritis in adults.7Publisher PDFPeer revieweThis publication has 6 references indexed in Scilit:
- Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasisBritish Journal of Dermatology, 2009
- Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasisBritish Journal of Dermatology, 2008
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Risk of Myocardial Infarction in Patients With PsoriasisJAMA, 2006
- The Psychosocial Burden of PsoriasisAmerican Journal of Clinical Dermatology, 2005
- Psoriasis causes as much disability as other major medical diseasesJournal of the American Academy of Dermatology, 1999